Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma

Annals of Hematology

Volumn 90, Issue 1, 2011, Pages 111-112

  Cho, Chun Hung ^a   Hwang, Wen Lee ^a   Cheng, Shao Bin ^a   Lee, Teng Yu ^a   Teng, Chieh Lin ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PREDNISOLONE; RITUXIMAB; VINCRISTINE; VIRUS DNA;

ABDOMINAL DISCOMFORT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; FEMALE; HEPATITIS B; HUMAN; LARGE CELL LYMPHOMA; LETTER; LIVER FUNCTION TEST; MAINTENANCE THERAPY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION; VIRUS REACTIVATION;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LYMPHOMA; VIRUS ACTIVATION;

EID: 78651345227     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0962-9     Document Type: Letter

References (10)

1. W Yeo PJ Johnson 2006 Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy Hepatology 43 209 220 1:CAS:528:DC%2BD28XhvVSgu7o%3D 10.1002/hep.21051 16440366
2. SN Pei CH Chen CM Lee MC Wang MC Ma TH Hu, et al. 2010 Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients Ann Hematol 89 255 262 1:CAS:528:DC%2BC3cXpsVSiug%3D%3D 10.1007/s00277-009-0806-7 19697028
3. MH van Oers R Klasa RE Marcus M Wolf E Kimby RD Gascoyne, et al. 2006 Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial Blood 108 3295 3301 10.1182/blood-2006-05-021113 16873669 (Pubitemid 44794222)
4. SH Lim Y Zhang Z Wang WV Esler D Beggs B Pruitt, et al. 2005 Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia Bone Marrow Transplant 35 207 208 1:CAS:528:DC%2BD28XhtFCrtbbM 10.1038/sj.bmt.1704742 15531902 (Pubitemid 40185940)
5. LE van der Kolk JW Baars MH Prins MH van Oers 2002 Rituximab treatment results in impaired secondary humoral immune responsiveness Blood 100 2257 2259 12200395
6. A Pyrpasopoulou S Douma T Vassiliadis S Chatzimichailidou A Triantafyllou S Aslanidis 2009 Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis Rheumatol Int. 10.1007/s00296-009-1202-2 19830433
7. Y Tsutsumi A Shigematsu S Hashino J Tanaka K Chiba N Masauzi, et al. 2009 Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido Ann Hematol 88 375 377 10.1007/s00277-008- 0585-6 18726097
8. YF He YH Li FH Wang WQ Jiang RH Xu XF Sun, et al. 2008 The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma Ann Hematol 87 481 485 1:CAS:528:DC%2BD1cXkvFSjtro%3D 10.1007/s00277-008-0454-3 18299831
9. A Bartholomeusz SA Locarnini 2006 Antiviral drug resistance. Clinical consequences and molecular aspects Semin Liver Dis 26 162 170 1:CAS:528:DC%2BD28Xltlegsrs%3D 10.1055/s-2006-939758 16673294 (Pubitemid 43668258)
10. TT Chang CL Lai YS Kew SS Lee HS Coelho FJ Carrilho, et al. 2010 Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 422 430 1:CAS:528: DC%2BC3cXisVGgurs%3D 20049753